Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease
The primary objective of this research was to evaluate the use of intravenous immunoglobulin (IVIG) in infants with hemolytic disease, to assess compliance with the American Academy of Pediatrics (AAP) guideline recommendations, and to review the data on which the guidelines were based. This retrosp...
Saved in:
Main Authors: | Daniel R. Mohan (Author), Hannah Lu (Author), Jacquelyn McClary (Author), Jaime Marasch (Author), Mary L. Nock (Author), Rita M. Ryan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Failure and Hyperbilirubinemia Secondary to Hemolytic Disease of the Newborn
by: Matthew Reinhardt, et al.
Published: (2024) -
Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
by: Eun Jung Cheon, et al.
Published: (2024) -
Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
by: E. Sedlin, et al.
Published: (2023) -
Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
by: Emel Okulu, et al.
Published: (2022) -
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
by: Kara B. Markham, et al.
Published: (2016)